Bafna Pharma. Half Yearly Results

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Sep-2019	Mar-2019	Sep-2018	--	--
Gross Sales	18.41	22.57	20.79	--	--
Excise Duty	--	--	--	--	--
Net Sales	18.41	22.57	20.79	--	--
Other Operating Income	--	--	--	--	--
Other Income	0.89	1.61	0.06	--	--
Total Income	19.31	24.18	20.85	--	--
Total Expenditure	21.66	34.28	22.42	--	--
PBIDT	(2.35)	(10.10)	(1.58)	--	--
Interest	0.17	0.68	1.45	--	--
PBDT	(2.52)	(10.78)	(3.03)	--	--
Depreciation	1.74	1.72	1.75	--	--
Minority Interest Before NP	--	--	--	--	--
Tax	--	--	--	--	--
Deferred Tax	(1.54)	1.06	0.01	--	--
Reported Profit After Tax	(2.72)	(13.56)	(4.79)	--	--
Minority Interest After NP	--	--	--	--	--
Net Profit after Minority Interest	(2.72)	(13.56)	(4.79)	--	--
Extra-ordinary Items	--	1.01	--	--	--
Adjusted Profit After Extra-ordinary item	(2.72)	(14.57)	(4.79)	--	--
EPS (Unit Curr.)	(1.15)	--	(3.01)	--	--
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	--	--	--
Equity	23.66	23.66	23.66	--	--
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	(12.77)	(44.75)	(7.60)	--	--
PBDTM(%)	--	--	--	--	--
PATM(%)	(14.78)	(60.08)	(23.04)	--	--